Carregando…
Nanotherapeutics in transplantation: How do we get to clinical implementation?
Patients undergoing organ transplantation transition from one life‐altering issue (organ dysfunction) to a lifelong commitment—immunosuppression. Regimens of immunosuppressive agents (ISAs) come with significant side effects and comorbidities. Recently, the use of nanoparticles (NPs) as a solution t...
| Principais autores: | , , , , , |
|---|---|
| Formato: | Online Atigo Texto |
| Idioma: | English |
| Publicado em: |
John Wiley and Sons Inc.
2022
|
| Assuntos: | |
| Acesso em linha: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081154/ https://www.ncbi.nlm.nih.gov/pubmed/35224837 http://dx.doi.org/10.1111/ajt.17012 |